| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | argenx SE | $919.94 | 0.3% | $56.93B | 46.9 | 279.7% | — | Healthcare | 68.5% | 174% | ||
| 2 | Spyre Therapeutics, Inc. | $88.89 | 0.1% | $30.76B | -44.9 | 12.4% | — | Healthcare | 481% | — | ||
| 3 | Kymera Therapeutics, Inc. | $119.24 | 3.9% | $9.74B | -32.3 | -15.5% | — | Healthcare | 172.2% | -12.6% | ||
| 4 | Abivax S.A. | $142.17 | -1.3% | $9.32B | -26.8 | 16.6% | — | Healthcare | 1688.3% | -100% | ||
| 5 | Protagonist Therapeutics, Inc. | $140.85 | 7.1% | $9.06B | -68.7 | -341.3% | — | Healthcare | 182.4% | -91.5% | ||
| 6 | Apogee Therapeutics, Inc. | $133.54 | 0% | $8.26B | -31.6 | -19.3% | — | Healthcare | 240.3% | — | ||
| 7 | Immunovant, Inc. | $40.09 | 3.9% | $8.23B | -14.5 | -1.5% | — | Healthcare | 144.2% | — | ||
| 8 | TG Therapeutics, Inc. | $53.52 | -2.6% | $8.19B | 19.3 | 1070.7% | — | Healthcare | 48.7% | 81.3% | ||
| 9 | Apellis Pharmaceuticals, Inc. | $41.03 | 0% | $5.25B | 227.9 | 150.8% | — | Healthcare | 135.5% | 32.6% | ||
| 10 | Kiniksa Pharmaceuticals, Ltd. | $67.29 | 7.2% | $4.99B | 89.7 | 471.4% | — | Healthcare | 140.8% | 56.7% | ||
| 11 | Dianthus Therapeutics, Inc. | $95.76 | 2.6% | $4B | -22.8 | 96.2% | — | Healthcare | 424.7% | -79.5% | ||
| 12 | Forte Biosciences, Inc. | $22.25 | 9% | $3.97B | -4.7 | 66.8% | — | Healthcare | 75.9% | — | ||
| 13 | Alumis Inc. Common Stock | $29.27 | 7.3% | $3.66B | -10.2 | 69.7% | — | Healthcare | 784.3% | -51.7% | ||
| 14 | Oruka Therapeutics, Inc. | $84.50 | 1.6% | $3.16B | -36.6 | 54.5% | — | Healthcare | 535.8% | — | ||
| 15 | Vera Therapeutics, Inc. | $42.96 | 7.1% | $3.08B | -9.2 | -77% | — | Healthcare | 87% | — | ||
| 16 | AnaptysBio, Inc. | $67.33 | 8% | $2.9B | -146.4 | 78% | — | Healthcare | 330.7% | 107.7% | ||
| 17 | Aurinia Pharmaceuticals Inc. | $16.22 | 4.7% | $2.09B | 7.8 | 675.6% | — | Healthcare | 117.1% | 20.6% | ||
| 18 | Galapagos N.V. | $27.98 | 2.2% | $1.84B | 5.0 | 379.9% | — | Healthcare | -1.8% | 262.2% | ||
| 19 | Nektar Therapeutics | $74.90 | 2.4% | $1.46B | -7.7 | 11.6% | — | Healthcare | 219.1% | -36.2% | ||
| 20 | KalVista Pharmaceuticals, Inc. | $27.00 | 0% | $1.44B | -8.4 | 13.9% | — | Healthcare | 79.3% | — | ||
| 21 | MoonLake Immunotherapeutics | $19.15 | 1.4% | $1.41B | -5.4 | -68.7% | — | Healthcare | -59.7% | — | ||
| 22 | Annexon, Inc. | $6.43 | 7.9% | $1.25B | -4.8 | -3.4% | 0.2% | Healthcare | 135.5% | — | ||
| 23 | Zenas BioPharma, Inc. | $27.68 | 4.7% | $1.24B | -3.3 | -129.2% | — | Healthcare | 182.7% | -100% | ||
| 24 | DBV Technologies S.A. | $17.35 | 11.1% | $1.03B | -0.7 | 11.8% | — | Healthcare | 57.6% | -100% | ||
| 25 | Ventyx Biosciences, Inc. | $14.00 | 0% | $999M | -7.1 | 36.4% | — | Healthcare | 586.3% | — | ||
| 26 | Climb Bio, Inc. | $13.42 | 1.1% | $915M | -15.3 | 67.2% | — | Healthcare | 965.1% | — | ||
| 27 | ZyVersa Therapeutics, Inc. | $0.11 | -28.3% | $894M | -0.0 | 57.3% | — | Healthcare | -83.3% | -100% | ||
| 28 | Rigel Pharmaceuticals, Inc. | $42.56 | 5.7% | $787M | 2.2 | 804.3% | — | Healthcare | 125.9% | 47.6% | ||
| 29 | Omeros Corporation | $10.33 | -0.1% | $748M | -196.0 | 149.1% | — | Healthcare | 235.4% | — | ||
| 30 | Jade Biosciences, Inc. | $22.45 | 5.4% | $732M | -5.5 | 95.6% | — | Healthcare | 114.8% | — | ||
| 31 | Gyre Therapeutics, Inc. | $7.01 | -3.4% | $680M | 311.6 | -8.9% | — | Healthcare | -8% | 16.3% | ||
| 32 | FibroGen, Inc. | $7.50 | 0.3% | $585M | -15.6 | 678.3% | 0.3% | Healthcare | 39.7% | -218.3% | ||
| 33 | Palisade Bio, Inc. | $2.08 | 2% | $436M | -6.9 | 83.6% | — | Healthcare | 183.4% | — | ||
| 34 | Zura Bio Limited | $5.08 | -5.2% | $330M | -4.8 | -29.8% | — | Healthcare | 361.8% | — | ||
| 35 | RAPT Therapeutics, Inc. | $58.01 | 0% | $296M | -2.3 | 50.2% | — | Healthcare | 610.8% | — | ||
| 36 | Cartesian Therapeutics, Inc. | $10.05 | -2.8% | $295M | -2.0 | -325.7% | — | Healthcare | -6.7% | -94.8% | ||
| 37 | Equillium, Inc. | $2.88 | 4% | $277M | -7.4 | 2.9% | — | Healthcare | 802.8% | -100% | ||
| 38 | Eledon Pharmaceuticals, Inc. | $3.93 | -1% | $236M | -7.0 | 60.7% | — | Healthcare | 26.4% | — | ||
| 39 | Avalo Therapeutics, Inc. | $19.25 | -3.6% | $217M | -3.3 | -124.1% | — | Healthcare | 305.3% | -86.6% | ||
| 40 | SeaStar Medical Holding Corporation | $5.07 | 6.5% | $199M | -0.9 | 88.2% | — | Healthcare | 824% | 235.5% | ||